FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

24684311000001109: Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Jul 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
80152401000001111 Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80152501000001110 Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Is a Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Has active ingredient Drospirenone false Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Has specific active ingredient Drospirenone true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Is a Cleosensa true Inferred relationship Existential restriction modifier
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) 63 tablet 3 x 21 tablets Has AMP True Cleosensa 0.03mg/3mg tablets (Actavis UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start